Fertility and Sterility
Volume 90, Issue 5 , Pages 1826-1833 , November 2008

Is there a role for soy isoflavones in the therapeutic approach to polycystic ovary syndrome? Results from a pilot study

  • Daniela Romualdi, M.D.

      Affiliations

    • Department of Obstetrics and Gynaecology, Università Cattolica del Sacro Cuore, Rome, Italy
    • ,
  • Barbara Costantini, M.D.

      Affiliations

    • Department of Obstetrics and Gynaecology, Università Cattolica del Sacro Cuore, Rome, Italy
    • ,
  • Giuseppe Campagna, M.D.

      Affiliations

    • Department of Obstetrics and Gynaecology, Università Cattolica del Sacro Cuore, Rome, Italy
    • ,
  • Antonio Lanzone, M.D.

      Affiliations

    • Department of Obstetrics and Gynaecology, Università Cattolica del Sacro Cuore, Rome, Italy
    • “Oasi” Institute for Research, Troina, Italy
    • ,
  • Maurizio Guido, M.D., Ph.D.

      Affiliations

    • Department of Obstetrics and Gynaecology, Università Cattolica del Sacro Cuore, Rome, Italy
    • Corresponding Author InformationReprint requests: Maurizio Guido, M.D., Ph.D., Department of Obstetrics and Gynaecology, Università Cattolica del Sacro Cuore, Largo Agostino Gemelli, 8, 00168 Rome, Italy (FAX: 39-06-3057794).

Received 10 July 2007 ,Revised 13 September 2007 ,Accepted 13 September 2007.

References 

  1. Barber TM, McCarthy MI, Wass JA, Franks S. Obesity and polycystic ovary syndrome. Clin Endocrinol (Oxf). 2006;65:137–145
  2. Apridonidze T, Essah PA, Iuorno MJ, Nestler JE. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005;90:1929–1935
  3. Bhathena SJ, Velasquez MT. Beneficial role of dietary phytoestrogens in obesity and diabetes. Am J Clin Nutr. 2002;76:1191–1201
  4. Setchell KD. Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr. 1998;68:1333S–1346S
  5. Adlercreutz H, Hockerstedt K, Bannwart C, Bloigu S, Hamalainen E, Fotsis T, et al. Effect of dietary components, including lignans and phytoestrogens, on enterohepatic circulation and liver metabolism of estrogens and on sex hormone binding globulin (SHBG). J Steroid Biochem. 1987;27:1135–1144
  6. Cassidy A, Bingham S, Setchell KD. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr. 1994;60:333–340
  7. Lu LJ, Anderson KE, Grady JJ, Nagamani M. Effects of soya consumption for one month on steroid hormones in premenopausal women: implications for breast cancer risk reduction. Cancer Epidemiol Biomarkers Prev. 1996;5:63–70
  8. Sirtori CR, Agradi E, Conti F, Mantero O, Gatti E. Soybean-protein diet in the treatment of type-II hyperlipoproteinaemia. Lancet. 1977;1:275–277
  9. Descovich GC, Ceredi C, Gaddi A, Benassi MS, Mannino G, Colombo L, et al. Multicentre study of soybean protein diet for outpatient hyper-cholesterolaemic patients. Lancet. 1980;4:709–712
  10. Anthony MS, Clarkson TB, Hughes CL, Morgan TM, Burke GL. Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. J Nutr. 1996;126:43–50
  11. Nogowski L, Mackowiak P, Kandulska K, Szkudelski T, Nowak KW. Genistein-induced changes in lipid metabolism of ovariectomized rats. Ann Nutr Metab. 1998;42:360–366
  12. Jayagopal V, Albertazzi P, Kilpatrick ES, Howarth EM, Jennings PE, Hepburn DA, et al. Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes. Diabetes Care. 2002;25:1709–1714
  13. Fedorak RN, Cheeseman CI, Thomson AB, Porter VM. Altered glucose carrier expression: mechanism of intestinal adaptation during streptozocin-induced diabetes in rats. Am J Physiol. 1991;261:G585–G591
  14. Persaud SJ, Harris TE, Burns CJ, Jones PM. Tyrosine kinases play a permissive role in glucose-induced insulin secretion from adult rat islets. J Mol Endocrinol. 1999;22:19–28
  15. The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group . Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41–47
  16. Belosi C, Selvaggi L, Apa R, Guido M, Romualdi D, Fulghesu AM, et al. Is the PCOS diagnosis solved by ESHRE/ASRM 2003 consensus or could it include ultrasound examination of the ovarian stroma?. Hum Reprod. 2006;21:3108–3115
  17. Fulghesu AM, Ciampelli M, Belosi C, Apa R, Pavone V, Lanzone A. A new ultrasound criterion for the diagnosis of polycystic ovary syndrome: the ovarian stroma/total area ratio. Fertil Steril. 2001;76:326–331
  18. New MI, Lorenzen F, Lerner AJ, Kohn B, Oberfield SE, Pollack MS, et al. Genotyping steroid 21-hydroxilase deficiency: hormonal reference data. J Clin Endocrinol Metab. 1983;57:320–326
  19. Ciampelli M, Fulghesu AM, Cucinelli F, Pavone V, Ronsisvalle E, Guido M, et al. Impact of insulin and body mass index on metabolic and endocrine variables in polycystic ovary syndrome. Metabolism. 1999;48:167–172
  20. De Fronzo JP, Tobin JD, Andrei R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237:E214–E223
  21. Bergman RN, Finegood DT, Ader M. Assessment of insulin sensitivity in vivo. Endocr Rev. 1985;6:45–86
  22. Faber OK, Christensen K, Kehelet H, Madsbad S, Binder C. Decreased insulin removal contributes to hyperinsulinemia in obesity. J Clin Endocrinol Metab. 1981;53:618–621
  23. Loon AT. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2000;23:S4–S19
  24. Cucinelli F, Paparella PL, Soranna L, Barini A, Cinque B, Mancuso S, et al. Differential effect of transdermal estrogen plus progestagen replacement therapy on insulin metabolism in postmenopausal women: relation to their insulinemic secretion. Eur J Endocrinol. 1999;140:1215–1223
  25. Lanzone A, Fulghesu AM, Fortini A, Cutillo G, Cucinelli F, Di Simone M, et al. Effect of opiate receptor blockade on the insulin response to oral glucose load in polycystic ovarian disease. Hum Reprod. 1991;6:1043–1049
  26. Van Hooff MH, Voorhorst FJ, Kaptein MB, Hirasing RA, Koppenaal C, Schoemaker J. Endocrine features of polycystic ovary syndrome in a random population sample of 14-16 year old adolescents. Hum Reprod. 1999;14:2223–2229
  27. Murkies AL, Wilcox G, Davis SR. Clinical review 92: phytoestrogens. J Clin Endocrinol Metab. 1998;83:297–303
  28. Erdman JW, Badger TM, Lampe JW, Setchell KD, Messina M. Not all soy products are created equal: caution needed in interpretation of research results. J Nutr. 2004;134:229S–1233S
  29. Kuiper GGJM, Lemmen JG, Carlsson B. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor ß. Endocrinology. 1998;139:4252–4263
  30. Duncan AM, Merz BE, Xu X, Nagel TC, Phipps WR, Kurzer MS. Soy isoflavones exert modest hormonal effects in premenopausal women. J Clin Endocrinol Metab. 1999;84:192–197
  31. Yoo RY, Dewan A, Basu R, Newfield R, Gottschalk M, Chang RJ. Increased luteinizing hormone pulse frequency in obese oligomenorrheic girls with no evidence of hyperandrogenism. Fertil Steril. 2006;85:1049–1056
  32. Wu AH, Stanczyk FZ, Hendrich S, Murphy PA, Zhang C, Wan P, et al. Effects of soy foods on ovarian function in premenopausal women. Br J Cancer. 2000;82:1879–1886
  33. Lu LJ, Anderson KE, Grady JJ, Kohen F, Nagamani M. Decreased ovarian hormones during a soya diet: implications for breast cancer prevention. Cancer Res. 2000;60:4112–4121
  34. Cassidy A, Bingham S, Setchell K. Biological effects of isoflavones in young women: importance of the chemical composition of soybean products. Br J Nutr. 1995;74:587–601
  35. Kellis JT, Vickery LE. Inhibition of human estrogen synthetase (aromatase) by flavones. Science. 1984;225:1032–1034
  36. Mousavi Y, Adlercreutz H. Genistein is an effective stimulator of sex hormone-binding globulin production in hepatocarcinoma human liver cancer cells and suppresses proliferation of these cells in culture. Steroids. 1993;58:301–304
  37. Pino AM, Valladares LE, Palma MA, Mancilla AM, Yanez M, Albala C. Dietary isoflavones affect sex hormone-binding globulin levels in postmenopausal women. J Clin Endocrinol Metab. 2000;85:2797–2800
  38. Vedavanam K, Srijayanta S, O'Reilly J, Raman A, Wiseman H. Antioxidant action and potential antidiabetic properties of an isoflavonoid-containing soyabean phytochemical extract (SPE). Phytother Res. 1996;13:601–608
  39. Wagner JD, Cefalu WT, Anthony MS, Litwak KN, Zhang L, Clarkson TB. Dietary soy protein and estrogen replacement therapy improve cardiovascular risk factors and decrease aortic cholesteryl ester content in ovariectomized cynomolgus monkeys. Metabolism. 1997;46:698–705
  40. Blakesmith SJ, Lyons-Wall PM, George C, Joannou GE, Petocz P, Samman S. Effects of supplementation with purified red clover (Trifolium pratense) isoflavones on plasma lipids and insulin resistance in healthy premenopausal women. Br J Nutr. 2003;89:467–474
  41. Hall WL, Vafeiadou K, Hallund J, Bugel S, Reimann M, Koebnick C, et al. Soy-isoflavone-enriched foods and markers of lipid and glucose metabolism in postmenopausal women: interactions with genotype and equol production. Am J Clin Nutr. 2006;83:592–600
  42. Hermansen K, Sondergaard M, Hoie L, Carstensen M, Brock B. Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects. Diabetes Care. 2001;24:228–233
  43. Merz-Demlow BE, Duncan AM, Wangen KE, Xu X, Carr TP, Phipps WR, et al. Soy isoflavones improve plasma lipids in normocholesterolemic, premenopausal women. Am J Clin Nutr. 2000;71:1462–1469
  44. Torres N, Torre-Villalvazo I, Tovar AR. Regulation of lipid metabolism by soy protein and its implication in diseases mediated by lipid disorders. J Nutr Biochem. 2006;17:365–373
  45. Sclavo M. Cardiovascular risk factors and prevention in women: similarities and differences. Ital Heart J. 2001;2(Suppl 2):125–141
  46. Castelli WP. The new pathophysiology of coronary artery disease. Am J Cardiol. 1998;82:60t–65t
  47. Abler A, Smith JA, Randazzo PA, Rothenberg PL, Jarett L. Genistein differentially inhibits postreceptor effects of insulin in rat adipocytes without inhibiting the insulin receptor kinase. J Biol Chem. 1992;267:3946–3951

 Supported by a grant from the Ministry of Public Health “La prevenzione dell'handicap mentale” Istituto di Ricovero e Cura a Carattere Scientifico Troina (Troina, Italy) and a grant from Ministero dell′Università e della Ricerca (Rome) 2005.

PII: S0015-0282(07)03641-2

doi: 10.1016/j.fertnstert.2007.09.020

Fertility and Sterility
Volume 90, Issue 5 , Pages 1826-1833 , November 2008

Article Tools

* Image Usage & Resolution